RCS - Inspiration Health - Launch of SLE1500 Non-Invasive Ventilator

Inspiration HealthcareAnnouncement

02/11/2023 07:16

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231102:nRSB0877Sa&default-theme=true

RNS Number : 0877S  Inspiration Healthcare Group PLC  02 November 2023

 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Launch of SLE1500 Non-Invasive Ventilator

Strengthens portfolio and expands access to neonatal respiratory market

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company pioneering best-in-class, specialist neonatal intensive care medical
devices, announces the launch of the SLE1500, the latest addition to its
specialist neonatal ventilator range. The SLE1500 is a compact respiratory
support system that provides non-invasive ventilation ("NIV") modes to meet
the needs of the smallest and most vulnerable neonatal patients requiring
respiratory support, helping to protect their fragile lungs.

 

NIV is considered the gold standard of care for preterm infants with
respiratory distress syndrome (RDS)(1) and is gradually becoming the first
choice for respiratory support(2). The SLE1500 has been specifically designed
to meet the special needs of some of the most vulnerable babies, starting in
the delivery room, to augment their first breaths of life and as they move
through their stay in neonatal intensive care. The SLE1500 system offers six
non-invasive delivery options in one machine; nasal Continuous Positive Airway
Pressure (nCPAP) both flow and pressure controlled, high flow oxygen therapy,
and manual flow for use with therapies like bubble CPAP, all of which can be
augmented with Pulse Oximetry (SpO(2)) and / or automatic oxygen control (auto
FiO(2)) through OxyGenie®. Oxygenie®, the Company's patented algorithmic
oxygen controller, provides second by second control of oxygenation, allowing
the baby to spend more time in its target oxygen saturation and staff to spend
more time caring for the infant, thus improving outcomes.(3)

 

Neil Campbell, CEO of Inspiration Healthcare, commented: "We are delighted to
extend our differentiated best-in-class ventilator product range with the
launch of our new SLE1500 respiratory support system, which will enable us to
support more babies. The need for non-invasive ventilation is paramount for
the effective treatment and care of the smallest and most vulnerable neonates.
The SLE1500 strengthens our ventilator product range and complements our range
of respiratory consumables allowing us to offer better solutions to our
customers worldwide.

 

"Our initial launch is focused on the UK and Australia, with other market
introductions due to follow, subject to regulatory approvals. We are excited
about the potential for the SLE1500, which demonstrates a key part of our
growth strategy and our continued R&D commitment to pioneer innovative
technologies to help save lives daily."

 

1.Non-invasive ventilatory support in neonates: An evidence-based update
 Paediatric Respiratory Reviews
(https://urldefense.proofpoint.com/v2/url?u=https-3A__www.sciencedirect.com_journal_paediatric-2Drespiratory-2Dreviews&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=qE1yMNvX8OUmO7FV4SLAuFx81K4O8nrPcCbRUEpXKXA&m=u8RhRCASxiGgAyrOkv8cgZwCvducSlwlsBCkAzhhN4JdDBEccznW2c0A56KwC7IL&s=82WTadycHgvzH3GjeTjebdrSj6i_b1DEue3YTd4q8-I&e=)
 Volume 44
(https://urldefense.proofpoint.com/v2/url?u=https-3A__www.sciencedirect.com_journal_paediatric-2Drespiratory-2Dreviews_vol_44_suppl_C&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=qE1yMNvX8OUmO7FV4SLAuFx81K4O8nrPcCbRUEpXKXA&m=u8RhRCASxiGgAyrOkv8cgZwCvducSlwlsBCkAzhhN4JdDBEccznW2c0A56KwC7IL&s=j5BgrpkPL-k6EmL1vNtiKnsI76VRKxz0jBoAvJjRYhs&e=)
, December 2022, Pages 11-18 Ramadan
A. Mahmoud , Gerd Schmalisch , Abhishek Oswal, Charles Christoph
Roehr

2.Non-invasive Respiratory Support in Neonates: A Review of Current Evidence
and Practices Indian J Pediatr.
(https://urldefense.proofpoint.com/v2/url?u=https-3A__www.ncbi.nlm.nih.gov_pmc_articles_PMC8169393_&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=qE1yMNvX8OUmO7FV4SLAuFx81K4O8nrPcCbRUEpXKXA&m=u8RhRCASxiGgAyrOkv8cgZwCvducSlwlsBCkAzhhN4JdDBEccznW2c0A56KwC7IL&s=JakosL5bOVcdsnE8lYkw2fL_O3g_R06r4A41oRNJnlw&e=)
 2021; 88(7): 670–678.Rajendra Prasad Anne
(https://urldefense.proofpoint.com/v2/url?u=https-3A__pubmed.ncbi.nlm.nih.gov_-3Fterm-3DAnne-2520RP-255BAuthor-255D&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=qE1yMNvX8OUmO7FV4SLAuFx81K4O8nrPcCbRUEpXKXA&m=u8RhRCASxiGgAyrOkv8cgZwCvducSlwlsBCkAzhhN4JdDBEccznW2c0A56KwC7IL&s=Hw1-eBjW4aL-HHtn-B_BodEouF6HkI634vvy0ch1P4Q&e=)
1 and Srinivas Murki
(https://urldefense.proofpoint.com/v2/url?u=https-3A__pubmed.ncbi.nlm.nih.gov_-3Fterm-3DMurki-2520S-255BAuthor-255D&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=qE1yMNvX8OUmO7FV4SLAuFx81K4O8nrPcCbRUEpXKXA&m=u8RhRCASxiGgAyrOkv8cgZwCvducSlwlsBCkAzhhN4JdDBEccznW2c0A56KwC7IL&s=JydiuF7lJHED_AKS4K-S0hBwCC_yDKzDpkQWG8wcC4A&e=)

3.The effect of automated oxygen control on clinical outcomes in preterm
infants: a pre- and post-implementation cohort study European Journal of
Pediatrics (2021) 180:2107–2113 H. H. Salverda, N. J. Oldenburger1 & M.
Rijken, S. C. Pauws P. A. Dargaville, A. B. te Pas1

For further information, please contact:

 

 Inspiration Healthcare Group plc                                                Tel: +44 (0)330
                                                 175 0000
 Neil Campbell, Chief Executive Officer

 Alan Olby, Chief Financial Officer

 Walbrook PR Ltd (Media and Investor Relations)  Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
 Anna Dunphy                                     Mob: +44 (0) 7876 741 001
 Stephanie Cuthbert                              Mob: +44 (0) 7796 794 663
 Louis Ashe-Jepson                               Mob: +44 (0) 7747 515 393

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology
for use in neonatal intensive care & operating theatres. The Company
provides high quality innovative products to patients around the world which
help to improve patient outcomes and it actively invests in innovative product
opportunities and disruptive technologies.

 

The Company has key own brand products that can be used within the first days
of life to help premature and sick babies; helping resuscitation and
stabilisation in the first moments of life through to preventing brain damage
and both invasive and non-invasive respiratory support in terms of capital
equipment and disposable medical devices. Additionally, the Company has its
own range of products for maintaining normothermia pre, during and
post-surgery.

 

Since September 2019, the Company has acquired Vio Holdings a designer,
manufacturer and supplier of single use respiratory products and sterile
medical consumables and S.L.E., a leading designer, manufacturer and global
provider of neonatal ventilation products.  The Group generates approximately
58% of its revenues from export markets and more than half of its revenues
come from its own-branded products.

 

With product availability actively promoted to over 80 countries through a
distribution network, Inspiration Healthcare's success has been built on
continuous innovation, excellent customer service and an inherent commitment
to improving patient outcomes, working in close collaboration with key opinion
leaders across the globe.

 

In the UK and Ireland, the Group has direct sales teams selling Group Branded
and complementary products from third parties, with an additional range of
home healthcare products.  This is supported by Technical Support for planned
preventative maintenance and emergency assistance.

 

The Group operates from various sites in the UK for R&D, Marketing and
operations with manufacturing based in Croydon (south London) and Hailsham
(East Sussex).  The Group's Head Office is located in Crawley, a short
distance from London's Gatwick Airport.

 

Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com (http://www.inspirationhealthcaregroup.com)

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAEASFFEEDDFFA